Personalis - 53 Year Dividend History | PSNL
Historical dividend payout and yield for Personalis (PSNL) since 1972. The current TTM dividend payout for Personalis (PSNL) as of April 22, 2025 is $0.00. The current dividend yield for Personalis as of April 22, 2025 is 0.00%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.282B | $0.085B |
| Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.477B | 5.66 |
| Dr Reddy's Laboratories (RDY) | India | $11.411B | 21.77 |
| BridgeBio Pharma (BBIO) | United States | $6.430B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $1.876B | 1.36 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.717B | 16.02 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.109B | 6.71 |
| Taysha Gene Therapies (TSHA) | United States | $0.254B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.075B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.015B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.003B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |